BioSpace News Archive

Sernova Corp., a clinical-stage company and leader in cell therapeutics, announced that an abstract has been selected for an oral presentation at the 4th International Pancreas and Islet Transplant Association / Harvard Stem Cell Institute / Juvenile Diabetes Research Fund Summit, to be held from April 24-25, 2023 in Cambridge, Massachusetts.

TScan Therapeutics, Inc. today announced that the first patient has been dosed in its Phase 1 umbrella trial of TSC-100 and TSC-101 targeting minor histocompatibility antigens (MiHA) HA-1 and HA-2.

ASLAN Pharmaceuticals today announced that two abstracts on eblasakimab have been accepted for poster presentation at the 1st International Societies for Investigative Dermatology Meeting, taking place from May 10 to 13, 2023, in Tokyo, Japan.

AXIM Biotechnologies, Inc. (OTCQB: AXIM) (“AXIM Biotech,” “AXIM” or “the Company”), an international healthcare diagnostic solutions development company, announced today the filing of a provisional patent application with the U.S. Patent and Trademark Office (US PTO) for the innovative use of proprietary materials in its ocular diagnostic assays that significantly increases sample disbursement.